scholarly journals Periodontal Manifestations in Pregnant Women : Study of 208 pregnancies at the CHU Gabriel Touré, Bamako

Author(s):  
Ousseynou Diawara ◽  
Boubacar Ba ◽  
A Niang ◽  
A Bocoum ◽  
E.D Tchonang Mani ◽  
...  

Aims: The aims of this study was to investigate the epidemiological characteristics of periodontal disease observed in pregnant women attending antenatal clinics in the Department of Obstetric Gynecology CHU- Gabriel Touré of Bamako.Materials and Methods: We realized a transverse, analytical study based on the observation of the periodontal status of pregnant women over 2 months (May-July 2013), 208 observations identified prenatally. Data were collected from medical records, entered and analyzed using SPSS 19.0 software.Results: We included 189 cases (90, 90 %). The age group most affected was that of 20-29 years (52, 40 %) with a mean age of 26, 88 and extremes ranging from 10 to 45 years. Married women were represented, with 94, 70 % of the cases, they were multigravidae in 71, 00 % of cases. Housewives accounted for 40, 40 %. HIV positive women represented 14, 00 % of the sample. The CPITN index corresponding to the scaling was greater in patients, between 11 weeks and 41 weeks 'gestation.Conclusion: This study shows the high frequency of periodontal disease in pregnant women, hence the importance of partnership between healths professional's reproduction and those of oral cavity.

2021 ◽  
Vol 11 (4) ◽  
pp. 564-569
Author(s):  
Anastasiya Vanyarkina ◽  
Alla Petrova ◽  
Lyubov Rychkova ◽  
Ekaterina Moskaleva ◽  
Evgeniya Novikova

The purpose of this study was to determine the features of the course of pregnancy, delivery, and the postpartum period in HIV-positive women with a high risk of HIV vertical transmission. Methods and Results: A retrospective, longitudinal cohort study of mother-child pairs for the period from 2017 to 2019 was conducted in the Irkutsk City Perinatal Center (level III). The clinical observation group included HIV-positive women (n=213) and their newborn children with a high risk of perinatal immunodeficiency virus transmission (n=214). The findings of the conducted study demonstrated that most HIV-seropositive women with a high risk of HIV vertical transmission had an aggravated social history, a high prevalence of pelvic inflammatory diseases, and a high incidence of opportunistic and AIDS-defining conditions. Evaluation of PMTCT preventive complex showed that the target parameters in women with a high risk of HIV transmission were not reached: the first stage was performed for 49.3% of pregnant women with good ART adherence, the second stage – for 97.1% of obstetric patients, the third stage – in 100% of HIV perinatally exposed children. HIV RNA was detected in 3.7% of children, which evidences their antenatal infection. Conclusion: Development of efficient communication with HIV-positive women aimed at preservation of their health and decrease of logistic barriers to access to medical care.


2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Rachel Musomba ◽  
Frank Mubiru ◽  
Shadia Nakalema ◽  
Hope Mackline ◽  
Ivan Kalule ◽  
...  

Introduction. We aim to describe the time of entry into care and factors associated with being lost to program (LTP) in pregnant women on Option B Plus in an integrated HIV and antenatal care (ANC) clinic in Uganda. Methods. We included all pregnant women enrolled into the integrated HIV-ANC clinic from January 2012 to 31st July 2014, while the follow up period extended up to October 30th 2015. LTP was defined as being out of care for ≥3 months. Results. Overall 856 women were included. Only 36.4% (86/236) of the women were enrolled in the first trimester. Overall 69 (8.1%) were LTP. In the multivariate analysis older women (HR: 0.80 per five-year increase, CI: 0.64–1.0, and P=0.060) and women on ART at the time of pregnancy (0.58, CI: 0.34–0.98, and P=0.040) were more likely not to be LTP. Among women already on ART at the time of pregnancy no factor was associated with LTP. Conclusion. Our results suggest the need for interventions to enhance prompt linkage of HIV positive women to HIV services for ART initiation and for increased retention particularly in young and ART naive women.


2019 ◽  
Vol 14 (2) ◽  
pp. 108
Author(s):  
Nastiti Bandari Pratiwi ◽  
Zahroh Shaluhiyah ◽  
Antono Suryoputro

Background: Pregnant women with HIV positive is potential risk to transmit the virus to their infants. Prevention Mother to Child Transmittion (PMTCT) program is a solution for HIV women if they want to have children. However, most pregnant women detected HIV positive when they have been pregnant for more than 6 months through Provider initiated test and counselling (PITC). On the other hand, the data shows that the increasing number of HIV positive women who have been willing to have children.  This research aims to identify and examine the factors influence the plan of having children among HIV-positive women who access HIV treatment in Kariadi Hospital Semarang. Method: This study employs a quantitative research design with cross sectional approach, followed by qualitative study to explore the feeling and attitudes of women with HIV positive to plan of having children. There were 31 women involved in this study, selected with the criteria of fertile women HIV positive who have been taking antiretroviral therapy in Kariadi Hospital and willing to participate in this study. Qualitative data collected from two women who has been planning to have children. Quantitative data were analyzed by univariate, Chi-Square and multiple logistic regression. Whilst, qualitative data employ content analysis.Results: There were 16% of women with HIV positive who have been intending to have children in this study. The rest have not planned it because they worried if their pregnancy and delivery could transmit HIV to their infants. CD4 cell count, ARV access and women’s attitudes have significant correlation to the intention of having children among women with HIV positive. Comprehensive information about PMTCT and ARV were needed to deliver to fertile women with HIV positive.


2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Barbara Castelnuovo ◽  
Frank Mubiru ◽  
Ivan Kalule ◽  
Shadia Nakalema ◽  
Agnes Kiragga

Since 2012, the WHO recommends lifelong ART with TDF+FTC/3TC+EFV for all HIV-positive pregnant and breastfeeding women (Option B-plus). In this analysis we describe the proportion of early and late transmission in mothers with high retention in Kampala, Uganda. We included 700 pregnant women from January 2012 to August 2014 with a follow-up extended to August 2016; the median age was 31 years (IQR: 26–35), 36.3% in WHO stage 3/4; median CD4 count was 447 cells/μL (IQR: 301–651) and 73.3% were already on ART for a median time of 28 (IQR: 10–57) months; 52% infants were male and median weight was 3.2 Kg (IQR: 2.5–3.5). Five hundred and sixty-five (80.7%) infants had at least one test for HIV; 22 (3.1%) infants died, all with unknown serostatus; 3 tested positive at week 6 and one additional at months 12 and 18. Two of the mothers of the 4 HIV-positive infants were ART-naïve at the time of pregnancy. We report very low documented HIV transmission comparable with those reported in clinical trials settings; however, demonstrating the efficacy of Option B-plus in terms of averted transmission in routine settings is challenging since high proportion of infants do not have documented HIV tests.


2020 ◽  
Author(s):  
Marli Stela Santana ◽  
Maura Eunice João FILIPE

Abstract During pregnancy, maternal intake of nutrients and their nutritional status affects both mother and baby. Good nutritional status plays an important role for a healthy pregnancy, for this it is necessary that the pregnant woman have a healthy diet to assist in weight gain.Objective: To evaluate the pregestational and gestational nutritional status of HIV-positive women.Methods: This is a cross-sectional and descriptive study, conducted from August to November 2018 in which 171 HIV-positive pregnant women were selected at random, in order of arrival and submitted to nutritional assessment through the Global Subjective Evaluation, whose data collected, were analyzed using EpiInfo software version 7.2.Results: From the main results found it was observed the presence of maternal nutritional eutrophic, considering the pre-gestational Body Mass Index (BMI) of 107 (62.56%), and the gestational BMI of 94 (54.97%). It was found 31(18.12%) of pre-gestational overweight and 54 (28.07%) of overweight during pregnancy, and it was also observed that 12 (7%) of pregnant women were obese before pregnancy and 15 (15.28%) became obese during pregnancy. A significant association was found between pregestational BMI, height (p˂0.0001), gestational BMI, current weight (p˂0.0003), brachial perimeter (p˂0.002), and uterine height (p˂0.005).Conclusion: The results of this study indicate the need to develop nutritional care programs for HIV-positive women, in order to ensure an adequacy of their nutritional status.


2020 ◽  
Author(s):  
Dorothy T Chisare ◽  
Simbarashe Takuva ◽  
Tariro J. Basera ◽  
Natasha Khamisa ◽  
Jacqueline Witthuhn

Abstract Background In Zimbabwe, almost 25% of infants are born with low birth weight (LBW). LBW accounts for over half of the neonatal deaths in the country. Anaemia during pregnancy has been inconsistently associated with an increased risk of LBW. However, very little data is available from countries where HIV prevalence is high, wherein HIV is also known to be a common risk factor to LBW. This study examined the relationship between maternal anaemia and LBW among HIV-infected pregnant women in Zimbabwe. Methods This was a secondary data analysis of the 2015 Zimbabwe Demography and Health Survey. Data for 809 HIV positive women aged 15-49 years and their infants from all live births preceding the survey by 5 years were included in the study. Modified-Poisson regression methods were used to determine the association between anaemia and LBW while adjusting for other risk factors. Results The prevalence of maternal anaemia and LBW among the HIV-infected pregnant women was 42.3% (n=342) and 16.3% (n =132) respectively. The prevalence of LBW was14.6% (n=50) and 17.6% (n=82) among anaemic and non-anaemic HIV positive women respectively (p=0.264). HIV infected pregnant women with anaemia had a 25% less chance of giving birth to infants with LBW compared to HIV infected mothers without anaemia, however, the association was not statistically significant (RR 0.75; 95% CI 0.53- 1.05). Conclusions The findings demonstrate a high prevalence of anaemia and LBW among HIV infected pregnant women. Nonetheless, maternal anaemia was not associated with LBW. There is a need for adapted monitoring of HIV-positive pregnant women and affordable improved nutrition during antenatal care to reduce the risk of LBW infants and maternal anaemia levels. Further research examining the relationship between maternal anaemia and LBW among HIV positive pregnant women whilst factoring in the role of ART and the severity of anaemia is required.


2015 ◽  
Vol 2015 ◽  
pp. 1-10
Author(s):  
Michelle M. Gill ◽  
Heather J. Hoffman ◽  
Appolinaire Tiam ◽  
Florence M. Mohai ◽  
Majoalane Mokone ◽  
...  

Objective.To improve PMTCT and antenatal care-related service delivery, a pack with centrally prepackaged medicine was rolled out to all pregnant women in Lesotho in 2011. This study assessed acceptability and feasibility of this copackaging mechanism for drug delivery among pregnant and postpartum women.Methods.Acceptability and feasibility were assessed in a mixed method, cross-sectional study through structured interviews (SI) and semistructured interviews (SSI) conducted in 2012 and 2013.Results.290 HIV-negative women and 437 HIV-positive women (n=727) participated. Nearly all SI participants found prepackaged medicines acceptable, though modifications such as size reduction of the pack were suggested. Positive experiences included that the pack helped women take pills as instructed and contents promoted healthy pregnancies. Negative experiences included inadvertent pregnancy disclosure and discomfort carrying the pack in communities. Implementation was also feasible; 85.2% of SI participants reported adequate counseling time, though 37.8% felt pack use caused clinic delays. SSI participants reported improvement in service quality following pack introduction, due to more comprehensive counseling.Conclusions.A prepackaged drug delivery mechanism for ANC/PMTCT medicines was acceptable and feasible. Findings support continued use of this approach in Lesotho with improved design modifications to reflect the current PMTCT program of lifelong treatment for all HIV-positive pregnant women.


e-CliniC ◽  
2016 ◽  
Vol 4 (1) ◽  
Author(s):  
Caroline . Dumais ◽  
Rudy A Lengkong ◽  
Maya E Mewengkang

Abstract: This study aimed to obtain the relationship between obesity in pregnancy and preeclampsia. This was a retrospective analytical study with a case-control design by using data of patients’ medical records. Samples were pregnant women with obesity (IMT ≥30 kg/m2) at the last pregnancy that suffered from preeclampsia and obese pregnant women without preeclampsia at RSUP Prof. Dr. R. D. Kandou Manado from January, 2013 until December 2014. Data were processed by using SPSS 2.0. The results showed that the number of obese pregnant women that suffered from preeclampsia and obese pregnant women without preeclampsia was 60 people. Most of them suffered from preeclampsia were categorized as obesity I. The chi-square test showed a p value = 0.013 (<α = 0.05). Conclusion: There was a relationship between obesity at pregnancy with preeclampsia at pregnant women at RSUP Prof. Dr. R. D. Kandou Manado. Keywords: BMI, obesity, preeclampsia Abstrak: Penelitian ini bertujuan untuk mengetahui hubungan obesitas pada kehamilan dengan pre-eklampsia. Jenis pnelitian ini analitik retrospektif dengan desain case-control. Data penelitian diperoleh dari catatan rekam medis pasien. Sampel penelitian ini ialah wanita hamil dengan obesitas (IMT ≥ 30 kg/m2) pada akhir kehamilan yang menderita pre-eklampsia dan wanita hamil obes tanpa pre-eklampsia di RSUP Prof. Dr. R.D. Kandou Manado dari bulan Januari 2013 sampai Desember 2014. Data yang diperoleh diolah dengan menggunakan SPSS 2.0. Hasil penelitian memperlihatkan bahwa jumlah wanita hamil dengan obesitas yang menderita pre-eklampsia dan wanita obes tanpa pre-eklampsia sebanyak 60 orang. Sebagian besar responden dengan pre-eklampsia termasuk obesitas I. Hasil uji chi square dengan tingkat signifikan α = 0,05 mendapatkan nilai p = 0,013 (<α = 0,05). Simpulan: Terdapat hubungan antara obesitas pada kehamilan dengan pre-eklampsi pada wanita hamil di RSUP Prof. Dr. R. D. Kandou ManadoKata kunci: IMT, obesitas, pre-eklampsia


2020 ◽  
Vol 14 (08) ◽  
pp. 901-907
Author(s):  
Tung-Che Hung ◽  
Li-Cheng Lu ◽  
Mei-Hui Lin ◽  
Yu-Chia Hu ◽  
Chien-Yu Cheng ◽  
...  

Introduction: This study determined risk factors, obstetric comorbidities, and fetal conditions among HIV-positive mothers to improve their maternal care. Methodology: This retrospective case-control study included HIV-positive pregnant women 18 years of age or older and age-, parity-, and delivery method-matched HIV-negative controls between 2011 and 2018. Those who had stillbirth were excluded. Baseline demographics, labor process, CD4 count, plasma HIV viral load, and antiretroviral therapy (ART) regimen were recorded. Fetal conditions were recorded as well. Results: Forty HIV-positive women (45 parities; 22 via NSD, 23 via C/S) were included, with 45 HIV-negative parities as controls. Twenty-nine (72.5%) HIV-positive women had illicit drug use. In the HIV-positive group, 17% received ART prior to first perinatal visit, and 75.6% reached viral suppression pre-delivery. Zidovudine and ritonavir-boosted lopinavir were the majorly prescribed ART. Mild perineal lacerations via NSD were observed in HIV-positive women. Fetal body weight was lower in HIV- and ART-exposed fetuses (2665 vs 3010 g, p < 0.001). Preterm delivery PTB (28.9% vs 8.9%, p= 0.015) and small-for gestational age SGA (28.9% vs 8.8%, p = 0.003) rates were higher in the HIV-positive group. There was no vertical transmission of HIV. Conclusions: HIV-positive women tend to deliver fetuses with low body weight and have higher SGA and PTB rates. Given that most women received zidovudine and protease inhibitors, benefits of newer agents for HIV-positive pregnancies should be studied.


2018 ◽  
Vol 33 (2) ◽  
pp. 42-45
Author(s):  
N. N. Gibango ◽  
S. Mda ◽  
T. S. Ntuli

Background: Prematurity and low birthweight (LBW) deliveries amongst pregnant women infected with the human immunodeficiency virus (HIV) remain a challenge worldwide. The association between prematurity, LBW and antiretroviral therapy (ART) or prophylactic antiretroviral drug (ARV) exposure in pregnancy is unclear. This study evaluates the risk of delivering a premature and/or LBW infant among HIV-positive pregnant women on ART or prophylactic ARV.Methods: A cross-sectional study was conducted (April to October 2012). HIV-positive women on prophylactic ARV (dual therapy) or lifelong ART (triple therapy or HAART) were enrolled in the study. Women who did not have a documented HIV result during pregnancy, those tested before delivery and those found to be HIV-positive were considered as not exposed to ARV drugs during pregnancy. This group received a standard dose of nevirapine during labour. The control group was made up of HIV-negative women.Results: Of the 496 mothers enrolled in the study, 59% (288/496) were HIV-positive, of whom 72% (206/288) were on ART or prophylactic ARV. The mean age was 27.6 ± 6.5 years (15 to 47 years). The mean gestational age (GA) was 35.9 ± 3.6 weeks (24– 42 weeks). Infants’ birthweights ranged from 550 to 4 900 g (2.5 ± 0.9 kg). HIV-positive mothers not on ART or ARV prophylaxis were likely to deliver an infant at GA  28 weeks (p 0.05) or birthweight  1 000 g (p 0.05) compared with their counterparts. Conclusion: HIV-positive pregnant women not on ART or ARV prophylaxis were at a risk of delivering babies at GA  28 weeks or birthweight  1 000 g. There is a need to encourage early and regular attendance for antenatal care so that HIV-positive pregnant women can be identified and have access to treatment during pregnancy.


Sign in / Sign up

Export Citation Format

Share Document